Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Breast Cancer
			Extragonadal Germ Cell Tumor
			Infection
			Lung Cancer
			Lymphoma
			Ovarian Cancer
			Small Intestine Cancer
			Testicular Germ Cell Tumor
2		Additional conditions recognized in this trial
			Breast Neoplasms
			Central Nervous System Neoplasms
			Communicable Diseases
			Duodenal Neoplasms
			Ileal Neoplasms
			Intestinal Neoplasms
			Jejunal Neoplasms
			Lung Neoplasms
			Lymphoma, Large-Cell, Immunoblastic
			Lymphoma, Non-Hodgkin
			Neoplasms, Germ Cell and Embryonal
			Nervous System Neoplasms
			Ovarian Neoplasms
3		More general conditions related to this trial
			Adnexal Diseases
			Breast Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Duodenal Diseases
			Endocrine Gland Neoplasms
			Endocrine System Diseases
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Genital Diseases, Female
			Genital Neoplasms, Female
			Gonadal Disorders
			Ileal Diseases
			Immune System Diseases
			Immunoproliferative Disorders
			Intestinal Diseases
			Jejunal Diseases
			Lung Diseases
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Nervous System Diseases
			Ovarian Diseases
			Respiratory Tract Diseases
			Respiratory Tract Neoplasms
			Skin Diseases
			Thoracic Neoplasms
			Urogenital Neoplasms
4		Interventions listed in this trial
			levofloxacin
5		Additional drug interventions recognized in this trial
			Ofloxacin
6		More general drug interventions related to this trial
			Anti-Bacterial Agents
			Anti-Infective Agents
			Anti-Infective Agents, Urinary
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Renal Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			Cancer Research Campaign Clinical Trials Centre